Crystal Willingham

Title: Crystal Willingham: Innovator in Traumatic Brain Injury Biomarkers

Introduction

Crystal Willingham is a notable inventor based in Tempe, AZ (US). She has made significant contributions to the field of traumatic brain injury research. Her innovative work focuses on the discovery of biomarkers that can aid in the diagnosis and treatment of such injuries.

Latest Patents

Crystal Willingham holds a patent for "Temporal traumatic brain injury biomarkers and methods of use thereof." This patent describes a unique pipeline for biomarker discovery that employs domain antibody phage display, next-generation sequencing analysis, and nanotechnology strategies. The patent discloses temporal biomarkers of traumatic brain injury and their methods of use. In some embodiments, the temporal biomarkers are synthetic peptides comprising the HCDR3 sequences identified using the disclosed pipeline. Additionally, the synthetic peptides have less than 30 amino acid residues and comprise a biotin scaffold linked to the HCDR3 sequences.

Career Highlights

Crystal is affiliated with Arizona State University, where she continues her research and development in the field of traumatic brain injury. Her work has the potential to significantly impact the medical community and improve patient outcomes.

Collaborations

Crystal collaborates with talented individuals such as Briana Martinez and Sarah Stabenfeldt. Their combined expertise enhances the research efforts at Arizona State University.

Conclusion

Crystal Willingham is a pioneering inventor whose work on traumatic brain injury biomarkers is paving the way for advancements in medical diagnostics and treatment. Her contributions are invaluable to the field and hold promise for future innovations.